Evercore Wealth Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Evercore Wealth Management’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-2,000	Closed	-$30K	–	1087
2016 Q2	$30K	Hold	2,000	–	–	﹤0.01%	690
2016 Q1	$24K	Hold	2,000	–	–	﹤0.01%	692
2015 Q4	$32K	Hold	2,000	–	–	﹤0.01%	679
2015 Q3	$31K	Hold	2,000	–	–	﹤0.01%	667
2015 Q2	$49K	Hold	2,000	–	–	﹤0.01%	640
2015 Q1	$47K	Hold	2,000	–	–	﹤0.01%	638
2014 Q4	$50K	Hold	2,000	–	–	﹤0.01%	552
2014 Q3	$62K	Hold	2,000	–	–	﹤0.01%	581
2014 Q2	$52K	Hold	2,000	–	–	﹤0.01%	609
2014 Q1	$47K	Hold	2,000	–	–	﹤0.01%	606
2013 Q4	$50K	Hold	2,000	–	–	﹤0.01%	564
2013 Q3	$40K	Hold	2,000	–	–	﹤0.01%	589
2013 Q2	$42K	Buy	+2,000	New	+$35.7K	﹤0.01%	587

Evercore Wealth Management's SGNT Position: Q3 2016 in Review

Evercore Wealth Management sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 2,000 shares — an estimated $30K sold.

Evercore Wealth Management first reported a position in SGNT in Q2 2013 and held it in 13 quarters. The position peaked at $62K in Q3 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

Evercore Wealth Management reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
Evercore Wealth Management sold 2,000 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $30K.
Evercore Wealth Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 13 quarters.
Evercore Wealth Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $62K in Q3 2014.
0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Evercore Wealth Management's 13F filing for Q3 2016, filed 10 Nov 2016.